FDA Inspection 1091219 - Juno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb - May 15, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Juno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb, with an inspection on May 15, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Juno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb
Inspection Date: May 15, 2019
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 89b25f8e-a86e-4e63-b5fe-8315960c6869